Table 5

30-Day Outcome of Carotid Angioplasty/Stenting in Major Randomized Trials

StudyInclusion CriteriaStroke/Death Rate (%)
CAVATAS96% Symptomatic lesions10.0
SAPPHIREHigh surgical risk (symptomatic and asymptomatic)4.5
EVA-3SSymptomatic lesions9.6
SPACESymptomatic lesions6.8

CAVATAS = Carotid And Vertebral Artery Transluminal Angioplasty Study; EVA-3S = Endarterectomy Versus Angioplasty in patients with Symptomatic Severe carotid Stenosis trial; SAPPHIRE = Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy; SPACE = Stent-protected Percutaneous Angioplasty of the Carotid vs. Endarterectomy.